report
describ
applic
realtim
pcr
test
antivir
highli
pathogen
virus
lassa
viru
sar
coronaviru
ebola
viru
test
combin
classic
cell
cultur
quantit
realtim
pcr
readout
assay
lassa
viru
valid
ribavirin
show
ic
gml
smallscal
screen
identifi
class
imidazol
nucleosidenucleotid
analogu
antivir
activ
lassa
viru
analogu
contain
either
dinitril
diester
group
imidazol
mani
possess
acycl
sugar
sugar
phosphon
moieti
imidazol
ic
valu
activ
compound
rang
gml
compound
also
inhibit
replic
sar
coronaviru
ebola
viru
analog
assay
although
lesser
extent
lassa
viru
tive
administ
earli
infect
sever
case
lassa
fever
recent
import
europ
demonstr
even
stateoftheart
intens
care
prevent
fatal
outcom
ribavirin
treatment
initi
late
schmitz
et
al
report
describ
assay
test
potenti
antivir
compound
lassa
viru
highli
pathogen
virus
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
drosten
et
al
ebola
hemorrhag
fever
viru
feldmann
et
al
test
combin
classic
cell
cultur
realtim
pcr
class
imidazol
nucleosidenucleotid
analogu
identifi
show
inhibitori
activ
lassa
viru
lesser
extent
sarscov
ebola
viru
flowchart
test
shown
fig
vero
cell
plate
densiti
well
plate
twentyfour
hour
later
cell
infect
biosafeti
level
laboratori
lassa
viru
strain
av
multipl
infect
moi
sarscov
moi
ebola
viru
subtyp
zair
moi
l
inoculum
remov
h
replac
fresh
medium
complement
differ
concentr
compound
none
three
virus
show
cytopath
effect
cultur
condit
viru
rna
concentr
supernat
measur
realtim
pcr
exponenti
growth
phase
virus
fig
ie
day
lassa
viru
sarscov
day
ebola
viru
time
virus
grow
sever
order
magnitud
inhibitor
ad
rna
prepar
simpl
inexpens
method
boom
et
al
adopt
aliquot
supernat
mix
l
chaotrop
lysi
buffer
avl
qiagen
incub
room
temperatur
min
lysat
ad
mg
diatomac
silica
sigmaaldrich
suspend
l
ethanol
incub
agit
min
room
temperatur
diatomac
silica
pellet
centrifug
pellet
wash
l
buffer
qiagen
subsequ
l
buffer
qiagen
final
l
aceton
pellet
dri
c
rna
elut
l
water
quantit
realtim
pcr
assay
lassa
viru
sarscov
ebola
viru
zair
perform
purifi
rna
base
previous
publish
protocol
gibb
et
al
drosten
et
al
asper
et
al
detail
reaction
condit
given
tabl
vitro
transcript
pcr
target
region
amplifi
pcr
gener
standard
curv
quantif
viru
rna
supernat
select
experi
infecti
lassa
viru
particl
supernat
quantifi
immunofocu
assay
vero
cell
plate
inocul
serial
dilut
supernat
inoculum
remov
h
replac
methylcellulosemedium
overlay
day
incub
cell
fix
formaldehyd
permeabil
triton
block
fetal
calf
serum
wash
infect
cell
foci
detect
lassa
viru
nucleoprotein
np
specif
monoclon
antibodi
dilut
hufert
et
al
wash
incub
peroxidaselabel
antimous
igg
antibodi
dianova
foci
stain
tetramethylbenzidin
tmb
count
cell
growth
inhibit
cytotox
determin
mtt
method
mtt
solut
l
mgml
pb
ad
remain
supernat
cell
aliquot
supernat
taken
measur
viru
rna
infecti
particl
concentr
plate
incub
min
c
supernat
complet
remov
cell
fix
formaldehyd
min
tetrazolium
crystal
dissolv
ml
ethanol
min
extinct
measur
nm
concentr
requir
inhibit
viru
replic
ic
ic
calcul
fit
sigmoid
curv
data
follow
logarithm
transform
drug
concentr
curv
fit
perform
probit
regress
analysi
use
statgraph
plu
softwar
statist
graphic
inc
initi
experi
perform
lassa
viru
assay
valid
use
ribavirin
posit
control
fig
agreement
publish
data
relat
arenavirus
huggin
et
al
rodriguez
et
al
andrei
de
clercq
ribavirin
inhibit
lassa
viru
replic
ic
gml
ic
gml
furthermor
inhibit
kinet
measur
realtim
pcr
perfectli
correspond
kinet
measur
dembi
et
al
asper
et
al
reaction
base
brilliant
singlestep
quantit
rtpcr
kit
stratagen
l
rna
buffer
mm
mgcl
dntp
g
bovin
serum
albumin
sybrgreenbind
molecul
sg
drosten
sybrgreen
molecular
probe
u
stratascript
rt
u
surestart
taq
immunofocu
assay
fig
indic
realtim
pcr
use
measur
effect
compound
lassa
viru
replic
nucleosid
analogu
differ
chemic
class
avail
institut
test
use
assay
screen
three
differ
concentr
rang
gml
test
class
imidazol
nucleosidenucleotid
analogu
identifi
show
inhibitori
effect
lassa
viru
without
sever
affect
cell
growth
viabil
eighteen
compound
class
test
fig
tabl
particularli
activ
compound
analys
detail
use
realtim
pcr
immunofocu
assay
readout
fig
compound
show
similar
effect
lassa
viru
rna
infecti
particl
demonstr
valid
pcrbase
assay
ic
valu
determin
rna
concentr
data
rang
gml
ic
valu
rang
gml
tabl
assay
compound
show
signific
influenc
rapidli
grow
vero
cell
concentr
gml
fig
order
test
whether
class
nucleosid
analogu
show
broadspectrum
activ
complet
set
compound
also
test
sarscov
ebola
viru
tabl
virusspecif
effect
observ
less
toxic
compound
fig
c
howev
inhibit
effect
sarscov
ebola
viru
consider
lower
observ
lassa
viru
overlap
cell
toxic
higher
concentr
evid
sarscovor
ebola
virusspecif
effect
compound
due
toxic
studi
show
realtim
pcr
use
approach
determin
antivir
effect
compound
assay
provid
imparti
quantit
valu
viru
growth
cell
presenc
compound
broad
dynam
rang
ie
sever
order
magnitud
effect
compound
cell
growth
viabil
measur
cell
howev
labori
classic
method
plaqu
reduct
test
immunofluoresc
test
test
base
inhibit
virusinduc
cytopathogen
nucleosid
analogu
identifi
inhibitor
lassa
viru
replic
contain
heterocycl
ring
name
imidazol
number
nucleosid
analogu
contain
heterocycl
ring
imidazol
pyrazol
triazol
sinc
long
document
potent
antivir
antibacteri
antitumor
agent
de
clercq
luczak
srivastava
et
al
korbukh
et
al
smith
kirkpatrick
revankar
et
al
includ
limit
bredinin
gerber
et
al
potent
nucleosid
antibiot
contain
imidazol
ring
ribavirin
witkowski
et
al
smith
kirkpatrick
tam
et
al
crotti
et
al
lau
et
al
broadspectrum
antivir
agent
contain
triazol
nucleu
addit
possess
heterocycl
ring
target
compound
also
contain
acycl
sugar
sugar
phosphon
group
attach
heterocycl
ring
thu
mimic
part
whole
natur
sugar
sugar
phosphat
nucleosid
nucleotid
context
analogu
wide
known
potent
broadspectrum
antivir
name
acyclovir
guanin
schaeffer
et
al
kaplan
bain
emmert
de
clercq
et
al
pmeapmeg
adenineguanin
kramata
et
al
compton
et
al
nobl
goa
observ
sarscov
ebola
viru
also
inhibit
certain
extent
suggest
class
analogu
potenti
broadspectrum
antivir
activ
mode
action
complet
specul
may
differ
depend
chemic
characterist
given
compound
one
possibl
direct
inhibit
viru
replic
machineri
altern
analogu
might
affect
cellular
pathway
nucleotid
metabol
rna
synthesi
highli
replic
viru
like
lassa
viru
probabl
suscept
inhibit
nucleotid
metabol
correspond
cellular
process
inhibit
nucleotid
metabol
could
also
account
toxic
associ
compound
